Jackson Levin, Nina http://orcid.org/0000-0001-8095-424X
Zhang, Anao http://orcid.org/0000-0002-3199-1113
Reyes-Gastelum, David http://orcid.org/0000-0003-0428-3127
Chen, Debbie W. http://orcid.org/0000-0001-6562-7232
Hamilton, Ann S. http://orcid.org/0000-0001-5898-2308
Zebrack, Bradley http://orcid.org/0000-0001-7026-1984
Haymart, Megan R. http://orcid.org/0000-0002-1083-1575
Funding for this research was provided by:
National Cancer Institute (R01 CA201198, T32-CA-236621)
Agency for Healthcare Research and Quality (R01 HS024512)
National Institute of Diabetes and Digestive and Kidney Diseases (T32-DK-007245)
Article History
Received: 10 March 2021
Accepted: 23 June 2021
First Online: 11 October 2021
Declarations
:
: The study was approved by the University of Michigan (HUM00113715), the University of Southern California (HS-16–00646), the Committee for the Protection of Human Subjects (California State Institutional Review Board), the Georgia Department of Public Health, and the Emory University Institutional Review Boards (IRB00093983) and received approval from the California Cancer Registry. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: A waiver of written informed consent was obtained for all subjects in this study.
: Not applicable.
: The authors declare no competing interests.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Cancer Institute. The ideas and opinions expressed herein are those of the authors and endorsement by the State of California and State of Georgia Departments of Public Health, the NCI and CDC, or their contractors and subcontractors is not intended nor should be inferred.